Identification and construction of combinatory cancer hallmark–based gene signature sets to predict recurrence and chemotherapy benefit in stage II colorectal cancer

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1001/jamaoncol.2015.3413
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: 2 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
  2. National Research Council Canada
FormatText
TypeArticle
Journal titleJAMA Oncology
ISSN2374-2437
Abstract
LanguageEnglish
Peer reviewedYes
NPARC number21276885
Export citationExport as RIS
Report a correctionReport a correction
Record identifier89cc6375-90f9-4186-a753-2e1e4933b7ad
Record created2015-10-30
Record modified2016-05-09
Date modified: